Mink Net Income Applicable To Common Shares from 2010 to 2024

INKT Stock  USD 0.62  0.01  1.59%   
Mink Therapeutics Net Loss yearly trend continues to be comparatively stable with very little volatility. Net Loss will likely drop to about -26.5 M in 2024. Net Loss is the net income that remains after preferred dividends have been deducted, available to common shareholders. View All Fundamentals
 
Net Loss  
First Reported
2010-12-31
Previous Quarter
-25.2 M
Current Value
-26.5 M
Quarterly Volatility
2.9 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Mink Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mink Therapeutics' main balance sheet or income statement drivers, such as Net Interest Income of 584.4 K, Depreciation And Amortization of 118.7 K or Interest Expense of 216.6 K, as well as many indicators such as Price To Sales Ratio of 0.0355, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Mink financial statements analysis is a perfect complement when working with Mink Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Mink Therapeutics Correlation against competitors.
For more information on how to buy Mink Stock please use our How to Invest in Mink Therapeutics guide.

Latest Mink Therapeutics' Net Income Applicable To Common Shares Growth Pattern

Below is the plot of the Net Income Applicable To Common Shares of Mink Therapeutics over the last few years. It is the net income that remains after preferred dividends have been deducted, available to common shareholders. Mink Therapeutics' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Mink Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Net Income Applicable To Common Shares10 Years Trend
Pretty Stable
   Net Income Applicable To Common Shares   
       Timeline  

Mink Net Income Applicable To Common Shares Regression Statistics

Arithmetic Mean(24,273,899)
Coefficient Of Variation(12.13)
Mean Deviation1,700,290
Median(23,802,182)
Standard Deviation2,945,467
Sample Variance8.7T
Range14M
R-Value(0.28)
Mean Square Error8.6T
R-Squared0.08
Significance0.32
Slope(181,370)
Total Sum of Squares121.5T

Mink Net Income Applicable To Common Shares History

2024-26.5 M
2023-25.2 M
2022-28 M
2021-30.2 M
2020-16.2 M

About Mink Therapeutics Financial Statements

Mink Therapeutics shareholders use historical fundamental indicators, such as Net Income Applicable To Common Shares, to determine how well the company is positioned to perform in the future. Although Mink Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Mink Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Mink Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Net Loss-25.2 M-26.5 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Mink Stock Analysis

When running Mink Therapeutics' price analysis, check to measure Mink Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mink Therapeutics is operating at the current time. Most of Mink Therapeutics' value examination focuses on studying past and present price action to predict the probability of Mink Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mink Therapeutics' price. Additionally, you may evaluate how the addition of Mink Therapeutics to your portfolios can decrease your overall portfolio volatility.